Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01866904 · ClinicalTrials.gov registry record
Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients
A clinical trial, sponsored by AstraZeneca.
- Terminated
- Registry status
- 9,284
- Enrollment target
NCT01866904 is a clinical trial that was terminated before completion, run by AstraZeneca. The registered enrollment target is 9,284 participants.
The verdict
NCT01866904 was terminated before completion, sponsored by AstraZeneca.
- TERMINATED
- Registry status
- 9,284 participants
- Enrollment target
Study Summary
THis study is intended to provide contemporary data on the burden of disease in patients 1 to 3 years post-MI, including a description of patient characteristics, current treatment patterns, rate of major CV events, and healthcare resource utilization in a 'real world' patient population at high atherothrombotic risk.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,284 participants |
| Start Date | 2013-06-19 |
| Est. Completion | 2017-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01866904
The ClinicalTrials.gov registry entry for NCT01866904 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 9,284 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01866904 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01866904 about?
NCT01866904 is a clinical study titled "Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients". THis study is intended to provide contemporary data on the burden of disease in patients 1 to 3 years post-MI, including a description of patient characteristics, current treatment patterns, rate of major CV events, and healthcare resource utilization in a 'real world' patient population at high ath...
What is the current status of trial NCT01866904?
This trial is currently terminated. The enrollment target is 9,284 participants. The study started on 2013-06-19. Estimated completion is 2017-03-31.
Who is sponsoring clinical trial NCT01866904?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.